Researchers from Beaumont Hospital Describe Findings in Colon Cancer (Integrated multiplex analysis of cell death regulators in stage II colorectal cancer suggests patients with 'persister' cell profiles fail to benefit from adjuvant...).

The article discusses new findings from Beaumont Hospital regarding colon cancer, highlighting the lack of validated biomarkers for apoptosis sensitivity in chemotherapy. Topics discussed include the identification of apoptosis-resistant 'persister' cell profiles in stage II colorectal cancer patients, the use of multiplexed imaging to analyze cell death regulators, and the implications of these findings for adjuvant chemotherapy effectiveness.